KM
Kenneth Musisi

Publications (12)

Patterns of compensatory mutations in rpoA/B/C genes of multidrug resistant M. tuberculosis in Uganda
Article scientifique · 2025
Patterns of compensatory mutations in rpoA/B/C genes of multidrug resistant M. tuberculosis in Uganda
Article scientifique · 2025
The development and implementation of a proficiency testing program for SARS-CoV-2 using dried tube specimens in resource-limited countries
Article scientifique · 2024
Evaluating the effectiveness of Uganda’s Supranational TB Reference Laboratory quality management system training program
Article scientifique · 2023
Peer Review Report For: Second-line drug resistance markers as proxy indicators of time to sputum culture conversion among second-line drug resistant tuberculosis patients tested in Uganda: A cross-sectional study [version 1; peer review: 1 approved with reservations, 1 not approved]
Article scientifique · 2023
Impact of randomized blinded rechecking program on the performance of the AFB Microscopy Laboratory Network in Uganda: a decadal retrospective study
Article scientifique · 2023
Phylogenetic lineages of tuberculosis isolates and their association with patient demographics in Tanzania
Article scientifique · 2022
First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda
Article scientifique · 2022
Molecular characterisation of second-line drug resistance among drug resistant tuberculosis patients tested in Uganda: a two and a half-year’s review
Article scientifique · 2022
Implementation of GeneXpert MTB/Rif proficiency testing program: A Case of the Uganda national tuberculosis reference laboratory/supranational reference laboratory
Article scientifique · 2021
Epidemiological profile of patients with rifampicin-resistant tuberculosis: an analysis of the Uganda National Tuberculosis Reference Laboratory Surveillance Data, 2014–2018
Article scientifique · 2021
Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014–2016)
Article scientifique · 2019

Domaines principaux

Sciences de la santé12

Statistiques

Consultations22
Téléchargements0